ArticleBMC pulmonary medicine2026
Mobile phone auscultation to delineate pneumonia from other respiratory conditions and controls: a prospective cohort study.
Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundSeeking to develop technology for medical countermeasures in novel infectious pandemics, this funded project intended to use mobile phone auscultation (MPA) to enable frontline detection of respiratory disease for situations with limited diagnostic options. The overall objective of this research was to determine the feasibility of obtaining mobile phone recordings in Emergency Departments with the intention of creating accurate models of pneumonia diagnosis.
methodsThis prospective study enrolled participants in five predetermined cohorts: influenza A, pneumonia, acute bronchitis, other respiratory illness, and controls. Potential subjects were approached in one of three emergency departments (two urban and one rural). Recordings were obtained with mobile phones with no hardware modifications. Recordings sampled bilateral 5th intercostal sites during normal and deep respiration, along with one supraclavicular fossa egophonic recording. Recordings were analyzed with computational nonlinear dynamics which, when applied to auscultation data, represent biofluid dynamics. Maximal Lyapunov Exponent (MLE) and Correlation Dimension (Dcorr) were evaluated to confirm the presence of low dimensional chaos and applicability of Time Series Dynamics (TSD) modeling. Train and test sets were created by 80/20 random sampling of clustered records. TSD models were fitted separately to recordings and then combined into a single “composite” model. Binary classifiers were fitted from extracted features by using logistic regression.
resultsFrom Nov 21, 2023 to June 12, 2024, 292 subjects were enrolled (64 pneumonia, 59 influenza A, 38 acute bronchitis, 68 other respiratory, and 63 controls) with a mean age of 49 years (SD 17.2). Half of the subjects were male, 68.0% white and 29.2% black. Compared to all others, pneumonia subjects were older (58 years vs. 46 years), more likely male (56% vs. 48%), more likely white (77% vs. 66%), and more likely to have a tobacco history (77% vs. 68%). No completed recordings were excluded from the recording analysis. TSD modeling of egophonic, right normal breathing (RNB), and composite models all produced accurate results. In test analyses, the RNB (sens 85%, spec 81%) and egophonic (sens 85%, spec 86%) models performed best. The composite model achieved sensitivity 91%, specificity 87%, and area under the curve of 89%. The test models yielded one false negative and seven false positives.
conclusionThis study found that modeling of mobile phone auscultation recordings yielded excellent sensitivity, specificity, and area under the curve to delineate pneumonia from other respiratory illness and controls. Similar models could increase access to accurate diagnosis of multiple medical conditions, particularly for medical counter measures during disease outbreaks. Phase 2 will further characterize models for deployment in larger populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.